Preview data: all rankings, scores, votes, refresh labels, methodology, testing and editorial-process statements in Top 49 are illustrative demo content, not live measurements or documented reviews.
#5 in Health Monitoring Devices
of 17 ranked entries
Abbott · Prescription continuous glucose monitor
Abbott publishes its mean absolute relative difference figures openly, and the Libre 3’s factory calibration means no fingerstick confirmation is required for most users — a genuine convenience improvement over earlier sensor generations, not just a smaller form factor. Recorded specifics: regulatory status FDA-cleared (prescription), measures Glucose, price 400. Panel highlighted factory calibration removes routine fingerstick confirmation, published accuracy data available for independent review and smallest sensor form factor in its category. The reservation on record is insurance coverage varies significantly by plan and region.
Score breakdown
Each criterion is scored independently, then combined using the weights published on Health Monitoring Devices.
On the record
| Regulatory status | FDA-cleared (prescription) |
|---|---|
| Measures | Glucose |
| Price | $400 |
| Rating | 8.8 |
Panel verdict
What it gets right
Where it gives ground
1 appearance
From the same list
Omron Healthcare
Omron’s oscillometric cuffs are the type most often used in the validation studies cited when clinical guidelines recommend home blood pressure monitoring, and the Platinum model stores readings for two users without needing a phone nearby. It reports a number; interpreting it is a conversation with a clinician, not an app.
Dexcom · Prescription continuous glucose monitor
The G7 shrank the sensor and cut warm-up time to about 30 minutes without a meaningful hit to its published mean absolute relative difference against lab reference glucose values, the metric that determines whether a CGM is trustworthy for dosing decisions. It requires a prescription for a reason.
AliveCor
Six-lead personal ECG capture is a genuine step up from the single-lead cardiac trackers built into most smartwatches, and AliveCor’s AFib detection algorithm has been validated against 12-lead ECG in multiple peer-reviewed studies. It flags a rhythm for review; it does not read it for you.
ResMed · Prescription CPAP
Continuous positive airway pressure has decades of trial evidence behind it for moderate-to-severe obstructive sleep apnea, and the AirSense 11’s built-in modem lets a sleep physician review adherence data remotely. None of that helps if the mask doesn’t fit, still the most common reason people stop using it.
Apple · ECG app & Irregular Rhythm Notifications
The ECG app and irregular rhythm notification feature were evaluated in the Apple Heart Study, a large prospective study published in a major peer-reviewed journal, which also documented a meaningful false-positive rate that Apple’s own materials disclose rather than bury.
Withings
A clinically validated cuff that syncs readings automatically to a phone app without requiring Bluetooth pairing each time, aimed at the specific, well-documented problem of people abandoning home blood pressure logs because manual entry is tedious.
Withings
A scale that also captures a six-lead ECG and a nerve-activity screening while you stand on it — an unusually broad claim for a bathroom scale. The ECG function carries its own FDA clearance, while the segmental body composition estimate carries the same inherent limitations as any bioimpedance measurement.
Dexcom · Over-the-counter glucose biosensor
The first glucose biosensor the FDA cleared for over-the-counter sale, aimed at people not using insulin rather than replacing a prescription CGM for insulin-dosing decisions. The clearance is real and specific; it is not equivalent to the broader clearance held by Dexcom’s prescription G7.
Top 49 rankings are editorial. Scores are produced from the published criteria on each list and are refreshed on the cadence stated there. Figures shown across this section are curated demonstration data.